Cassandra Gath is a highly experienced professional who has worked in various roles in the biotechnology industry. Cassandra has expertise in downstream purification of recombinant viruses for CRISPR/Cas9 based therapies and has developed purification strategies for novel gene editing vectors. Additionally, Cassandra has experience in office coordination and research assistance in protein hormone proteolytic fragments. Cassandra has a Bachelor of Science in Biology/Biological Sciences from UMass Boston.
January, 2022 - present
July, 2020
November, 2019